A30 Leprosy [Hansen's disease]

Name of the Condition

• Leprosy [Hansen's disease]

Summary

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, primarily affecting the skin, peripheral nerves, mucosa of the upper respiratory tract, and eyes. The condition progresses slowly and can lead to progressive and permanent damage to the skin, nerves, limbs, and eyes if left untreated. It is characterized by skin lesions and nerve damage, with clinical manifestations varying based on the host's immune response.

Causes

Leprosy is caused by the bacterium Mycobacterium leprae. Transmission occurs through prolonged close contact with untreated individuals, typically via respiratory droplets from the nose or mouth. The bacteria invade the body and multiply slowly, primarily affecting cooler regions such as the skin and peripheral nerves.

Risk Factors

• Prolonged exposure to an untreated person with leprosy.
• Residence in or travel to regions with high leprosy prevalence (e.g., parts of Asia, Africa, and South America).
• Weakened immune system, which may increase susceptibility to infection.
• Genetic factors that influence the body's immune response to the bacteria.

Symptoms

• Skin lesions (hypopigmented or reddish patches) with reduced sensation.
• Numbness or loss of feeling in affected areas.
• Muscle weakness or paralysis, particularly in the hands and feet.
• Thickened nerves, often visible as enlarged peripheral nerves.
• Eye problems, including blurred vision or corneal damage.
• Nasal stuffiness or nosebleeds due to mucosal involvement.

Diagnosis

Diagnosis is based on clinical evaluation, including the presence of characteristic skin lesions and nerve involvement. Laboratory tests such as skin smears or biopsies may be performed to detect Mycobacterium leprae. Nerve function assessments and histopathological examination of tissue samples can also aid in confirmation.

Treatment Options

• Multidrug Therapy (MDT): The standard treatment involves a combination of antibiotics (e.g., dapsone, rifampicin, clofazimine) to eliminate the bacteria and prevent resistance.
• Corticosteroids: Used to manage acute nerve inflammation or reactions.
• Surgical Interventions: May be necessary to correct deformities or address complications like claw hand or foot drop.

Prognosis and Follow-Up

With early diagnosis and appropriate treatment, leprosy can be cured, and further nerve damage can be prevented. However, existing nerve damage is often irreversible. Regular follow-up is essential to monitor for reactions, assess nerve function, and ensure treatment completion. Lifelong surveillance may be recommended for some patients to detect relapse or complications.

Complications

• Permanent nerve damage leading to sensory loss, muscle weakness, or paralysis.
• Deformities of the hands, feet, or face.
• Eye damage, including blindness.
• Kidney or testicular involvement in severe cases.
• Social stigma and psychological distress.

Lifestyle & Prevention

• Avoid prolonged close contact with untreated individuals in high-prevalence areas.
• Practice good hygiene and sanitation.
• Seek early medical care if symptoms suggestive of leprosy appear.
• Follow public health guidelines in endemic regions, including screening and treatment programs.

When to Seek Professional Help

Consult a healthcare provider if you develop persistent skin lesions with reduced sensation, unexplained numbness, or nerve-related symptoms, especially after travel to or residence in high-risk areas. Early evaluation is critical to prevent irreversible damage.

Tips for Medical Coders

When coding for leprosy (A30), ensure documentation supports the clinical findings, including skin lesions, nerve involvement, or systemic manifestations. Note the type of leprosy (e.g., tuberculoid, lepromatous) if specified, as this may impact coding specificity. Verify that the diagnosis aligns with the ICD-10-CM guidelines for infectious diseases and confirm no conflicting documentation exists.